Posts

Lilly's triple agonist heads to regulators after two more Phase 3 obesity wins

on

Hengrui, Kailera’s GLP‑1 Pill Posts Encouraging Efficacy but High Side Effect Rates in Late‑Stage China Trials

on

US lawmakers intensify scrutiny of Chinese clinical trials, raising industry concerns over cost and disruption

on

Viridian's Lumvoa Gains FDA Nod for Thyroid Eye Disease, Setting Up Clash With Amgen's Tepezza

on

No recent news about former employee suing BioNTech for cutting corners in pancreatic cancer trials found in current search results. The available information does not mention any such lawsuit or allegations related to BioNTech or pancreatic cancer trials involving a former employee. Thus, there is no recent news on this specific claim at this time.

on

Isomorphic Labs, DeepMind Spinoff, Nears Human Trials for AI-Designed Drugs

on

Genentech Halts Emugrobart Development in Rare Genetic Muscle Diseases, Raising Concerns for Obesity Trials

on

Corsera Health Launches with $50M Funding for Preventive Cardiovascular RNAi Program Advancing to Clinic

on

AstraZeneca Furthers Ambition to Redefine Cancer Care with First Data from Four Major Pivotal Trials at ESMO 2025

on

Minghui Raises $131M to Advance PD-1xVEGF Bispecific Antibody Program

on

Rethinking Clinical Trial Data in the Era of Decentralization: Key Trends and Challenges (2025)

on

FDA Advisory Panel Rejects GSK's Blenrep in New Combinations Over Safety, Efficacy Concerns

on